Aggressive lymphoma of the skull in a patient with AIDS
Szucs-Farkas, Z.; Peltzer, J.; Berger, D.; Braunschweig, M.
Jbr-Btr Organe de la Societe Royale Belge de Radiologie 88(3): 152-153
2005
ISSN/ISBN: 0302-7430 PMID: 16038238 Document Number: 588455
Document emailed within 1 workday
Related Documents
Kasuya, A.; Hirakawa, S.; Tokura, Y. 2012: Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion Dermatology Online Journal 18(10): 5Hołowiecki, J.; Giebel, S.; Walewski, J.; Krawczyk-Kuliś, M.łg.; Hellmann, A.; Skotnicki, A.; Dmoszyńska, A.; Romejko, J.; Czyz, J.ła.; Jurczak, W.; Kachel, Łu.; Wojnar, J.; Stella-Hołowiecka, B.; Saduś-Wojciechowska, M.; Sułek, K.; Jedrzejczak, W.ła.; Robak, T.; Mariańska, B.; Szczylik, C.; Warzocha, K. 2003: Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. the experience of Polish lymphoma research group Polskie Archiwum Medycyny Wewnetrznej 110(2): 863-868
Siani, L.M.; Siani, A.; Ricci, V.; D'Elia, M.; Masoni, T.; Uggeri, G. 2009: Burkitt's lymphoma of the caecum in a patient with AIDS: clinical case and review of the literature Minerva Chirurgica 64(2): 229-233
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Sasaki, M.das.Graças.; Leite, Pícia.G.B.; Leite, Aéa.G.B.; de Almeida, Sérgio.Monteiro. 2002: Bilateral peripheral facial palsy secondary to lymphoma in a patient with HIV/AIDS: a case report and literature review Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 6(1): 50-54
Armitage, J.O. 2005: The treatment of patients with aggressive non-Hodgkin's lymphoma Oncology 19(4 Suppl 1: 3-6
Coiffier, B.; Reyes, F. 2005: Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective Oncology 19(4 Suppl 1: 7-15
Sehn, L.H.; Connors, J.M. 2005: Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective Oncology 19(4 Suppl. 1): 26-34
Veselý, K. 2010: Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis Vnitrni Lekarstvi 56(11): 1114-1115
Bosly, A.; Coiffier, B. 1993: Place of autograft in the treatment of relapses of aggressive lymphoma: the GELA experience Pathologie-Biologie 41(1): 97
Sotnikov, V.M.; Pan'shin, G.A.; Datsenko, P.V.; Ivashin, A.V.; Smol'tsova, N.N. 2009: The role of adjuvant radiotherapy in the complex treatment of stage III-IV aggressive non-Hodgkin's lymphoma Voprosy Onkologii 55(4): 443-446
Moser, E.C.; Noordijk, E.M.; van Leeuwen, F.E.; Baars, J.W.; Thomas, Jé.; Carde, P.; Meerwaldt, J.H.; van Glabbeke, M.; Kluin-Nelemans, H.C. 2006: Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study Haematologica 91(11): 1481-1488
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Brice, P.; Lepage, E.; Gisselbrecht, C.; Fior, R.; Trédaniel, J.; d'Agay, M.F.; Boiron, M. 1990: Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment Nouvelle Revue Francaise D'hematologie 32(2): 153-157
Taguchi, H.; Shishido, T.; Niitsu, N.; Hiraoka, A.; Kageyama, T.; Kanamaru, A.; Ogawa, M. 1998: High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 523-529
Huttunen, M.O. 1992: The aggressive patient Duodecim; Laaketieteellinen Aikakauskirja 108(3): 261-270
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Khan, M.A.; Jakate, S.; Komanduri, S. 2010: Rare AIDS-associated plasmablastic lymphoma as the initial presentation of AIDS Clinical Advances in Hematology and Oncology: H&o 8(1): 55-57
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Lumb, P.D.; Dalton, B.; Bryan-Brown, C.W.; Donnelly, C. 1979: Aggressive approach to intravenous feeding of the critically ill patient Heart and Lung: the Journal of Critical Care 8(1): 71-80